ID   PaCaDD-159
AC   CVCL_M465
SY   PACADD-159; PACADD159
DR   cancercelllines; CVCL_M465
DR   Cell_Model_Passport; SIDM01330
DR   DepMap; ACH-001378
DR   DSMZ; ACC-745
DR   DSMZCellDive; ACC-745
DR   Wikidata; Q54937425
RX   CelloPub=CLPUB00002;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 41.3 hours (CelloPub=CLPUB00002); ~1 week (DSMZ=ACC-745).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (CelloPub=CLPUB00002; DepMap=ACH-001378).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pancreas, tail; UBERON=UBERON_0001151.
ST   Source(s): DepMap=ACH-001378; DSMZ=ACC-745
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 12,13
ST   D18S51: 19.2 (DSMZ=ACC-745)
ST   D18S51: 20 (DepMap=ACH-001378)
ST   D19S433: 14
ST   D21S11: 27,32.2
ST   D2S1338: 17,19
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 11,15
ST   FGA: 19,20
ST   Penta D: 11,13
ST   Penta E: 7,10
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
RX   CelloPub=CLPUB00002;
RA   Ruckert F., Werner K., Aust D., Hering S., Saeger H.-D.,
RA   Grutzmann R., Pilarsky C.;
RT   "Establishment and characterization of six primary pancreatic cancer
RT   cell lines.";
RL   Austin J. Cancer Clin. Res. 2:1055.01-1055.05(2015).
//